03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The government published its Good Work Plan back in December 2018 in response to Matthew Taylor's re...
Read More >
On January 13, 2020, the U.S. Department of Treasury, on behalf of the Committee on Foreign Investme...
Read More >
The US Federal Trade Commission (FTC) yesterday released decreased thresholds for the Hart-Scott-Rod...
Read More >
There may soon be a fair number of big-rig trucks for sale in California, as well as computers, desk...
Read More >
U.S. Department of Commerce proposes to regulate transactions involving Information and Communicatio...
Read More >
In today’s edition Sunday Book Review edition of Daily Compliance News we honor the author Andrea C...
Read More >